Cargando…

The use of HCV positive donors among non-HCV infected liver transplant recipients

Detalles Bibliográficos
Autores principales:	Zaffar, Duha, Muhammad, Haris, Gurakar, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2022
Materias:	Editorial - HCV +ve donors among non-HCV infected LT recipients
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138910/ https://www.ncbi.nlm.nih.gov/pubmed/35782374 http://dx.doi.org/10.14744/hf.2021.2021.0048

Ejemplares similares

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens
por: Shah, Rajiv, et al.
Publicado: (2021)

The cost‐effectiveness of testing for NS5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) subjects treated with all‐oral elbasvir/grazoprevir regimens in the United States
por: Elbasha, E. H., et al.
Publicado: (2016)

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation
por: Da, Ben L., et al.
Publicado: (2020)

An Update on Usage of High-Risk Donors in Liver Transplantation
por: Muhammad, Haris, et al.
Publicado: (2021)

Similar 5-Year Estimated Glomerular Filtration Rate Between Kidney Transplants From Uncontrolled and Controlled Donors After Circulatory Death—A Dutch Cohort Study
por: Peters-Sengers, Hessel, et al.
Publicado: (2017)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

Letter to the Editor: Living Donor Liver Transplantation During the COVID-19 Pandemic: An Evolving Challenge
por: Muhammad, Haris, et al.
Publicado: (2021)

Vocal Cord Monitoring by Flexible Fiberoptic Laryngoscopy During Thyroid Radiofrequency Ablation
por: Valcavi, Roberto, et al.
Publicado: (2023)

Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
por: Chen, Ruoyang, et al.
Publicado: (2021)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

Liver transplantation in hepatic myelopathy
por: Acar, Sencan, et al.
Publicado: (2022)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Assessing the discrimination of the Kidney Donor Risk Index/Kidney Donor Profile Index scores for allograft failure and estimated glomerular filtration rate in Ireland’s National Kidney Transplant Programme
por: Sexton, Donal J, et al.
Publicado: (2019)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Communicating the move to individualized donor selection policy: Framing messages focused on recipients and safety
por: Ferguson, Eamonn, et al.
Publicado: (2022)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Dilemma of HCV Infection in Renal Transplant Recipients
por: Ashry Ahmed Gheith, Osama
Publicado: (2011)

Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies
por: Saeed, Naba, et al.
Publicado: (2016)

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015)

Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke
por: Carlson, Steven K, et al.
Publicado: (2017)

Pericardial-esophageal fistula complicating cryoballoon ablation for refractory atrial fibrillation
por: Giacomino, Bria D., et al.
Publicado: (2017)

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome
por: Shi, Shaobo, et al.
Publicado: (2017)

Radiation-associated plasmacytoma following catheter ablation for atrial fibrillation
por: Chow, Justin, et al.
Publicado: (2016)

Hierarchical analysis of electrograms to guide termination of persistent atrial fibrillation
por: Porta-Sánchez, Andreu, et al.
Publicado: (2017)

Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy
por: Ellis, Ethan R.
Publicado: (2017)

The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation
por: Wieczorek-Godlewska, Renata, et al.
Publicado: (2017)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

Graft versus host disease after liver transplantation: A case report
por: Acar, Sencan, et al.
Publicado: (2022)

Exertional Heat Stroke-Induced Acute Liver Failure and Liver Transplantation
por: Lin, Jessica S., et al.
Publicado: (2022)

Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
por: Eckman, Mark H., et al.
Publicado: (2021)

Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
por: Steinbrink, Julie M., et al.
Publicado: (2023)

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
por: Bulfoni, Michela, et al.
Publicado: (2021)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
por: Guyenet, Stephan J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sgfqrrpanc09skcqvj8gdmfj98